Vivani Medical
VANI----
Vivani Medical (VANI)
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic dise...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Vivani Medical Analyst Rating
View MoreForecast & Rating
Jul 9, 2026Price forecast
$3.83189.31%
Forecast & RatingStrong buy
3analysts
- Strong buy66.67%
- Buy33.33%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 17 at 04:24 PM
ClearOne files draft information statement for Cortigent merger share issuance
- PUBT · Jul 16 at 08:00 AM
Vivani Medical director, 10% owner Gregg Williams reports purchase of USD 999,999 common shares
- TradingView · Jul 16 at 07:33 AM
Vivani Medical says first SLIM-1 dosing expected in August 2026 after CEO presentation
- Market Beat · Jul 15 at 06:02 PM
Vivani Medical Eyes August Human Trial for Semaglutide Implant After Novo Nordisk Deal
- Unusual Whales · Jul 14 at 03:04 PM
Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026
- CoinLive · Jul 11 at 07:02 AM
Novo Nordisk signs agreement with Vivani to evaluate semaglutide implant NPM-139
